You are here

Clinical Trials: Cardiovascular Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, December 13, 2017 - 12:00
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle sheet
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting
Posted: Wednesday, December 13, 2017 - 12:00
Conditions:   Hemorrhagic Stroke;   Intracerebral Hemorrhage
Intervention:   Biological: MSC
Sponsor:   Mayo Clinic
Recruiting
Posted: Wednesday, December 6, 2017 - 12:00
Condition:   Pseudoxanthoma Elasticum
Intervention:   Other: urine collection
Sponsors:   University Hospital, Angers;   Université de Nantes;   Hungarian Academy of Sciences
Not yet recruiting
Posted: Wednesday, November 22, 2017 - 12:00
Conditions:   Chronic Heart Failure;   Old Myocardial Infarction
Intervention:   Biological: Stem cells administered to participants
Sponsors:   Sakakibara Heart Institute;   CellBank of Japan
Not yet recruiting
Posted: Friday, November 10, 2017 - 12:00
Condition:   Peripheral Arterial Occlusive Disease
Interventions:   Biological: allo-APZ2-PAOD;   Drug: Placebo
Sponsors:   RHEACELL GmbH & Co. KG;   FGK Clinical Research GmbH;   TICEBA GmbH;   Granzer Regulatory Consulting & Services
Not yet recruiting
Posted: Thursday, October 19, 2017 - 12:00
Condition:   Antioxidant Intervention
Interventions:   Dietary Supplement: L-carnosine;   Other: placebo
Sponsor:   University of Louisville
Not yet recruiting
Posted: Monday, October 9, 2017 - 12:00
Condition:   Peripheral Artery Disease (PAD)
Interventions:   Drug: GM-CSF;   Drug: Placebo
Sponsors:   Emory University;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Posted: Friday, September 29, 2017 - 12:00
Condition:   Peripheral Arterial Disease
Interventions:   Biological: Platelet lysate;   Biological: Placebo
Sponsor:   Sophia Al-Adwan
Not yet recruiting
Posted: Monday, August 21, 2017 - 12:00
Condition:   Stem Cell Transplant
Intervention:   Drug: Stem Cell Product
Sponsor:   Assiut University
Not yet recruiting - verified August 2017
Posted: Thursday, August 17, 2017 - 12:00
Condition:   Skin Ulcer Venous Stasis Chronic
Intervention:   Biological: allo-APZ2-CVU
Sponsors:   Rheacell GmbH & Co. KG;   FGK Clinical Research GmbH;   TICEBA GmbH;   Granzer Regulatory Consulting & Services
Not yet recruiting - verified August 2017

Pages